Phytosterolaemia associated with parenteral nutrition administration in adult patients.


Journal

The British journal of nutrition
ISSN: 1475-2662
Titre abrégé: Br J Nutr
Pays: England
ID NLM: 0372547

Informations de publication

Date de publication:
28 06 2020
Historique:
pubmed: 23 2 2020
medline: 17 2 2021
entrez: 21 2 2020
Statut: ppublish

Résumé

Vegetable lipid emulsions (LE) contain non-declared phytosterols (PS). We aimed to determine PS content depending on the brand and LE batch, and in adult hospitalised patients treated with parenteral nutrition (PN), to establish the association between plasma and administered PS. Part I was the LE study: totals and fractions of PS in three to four non-consecutive batches from six LE were analysed. Part II was the patient study: patients with at least 7 previous days of PN with 0·8 g/kg per d of an olive/soyabean (O/S) LE were randomised (day 0) 1:1 to O/S or 100 % fish oil (FO) at a dose of 0·4 g/kg per d for 7 d (day 7). Plasma PS, its fractions, total cholesterol on days 0 and 7, their clearance and their association with PS administered by LE were studied. In part I, LE study: differences were found in the total PS, their fractions and cholesterol among different LE brands and batches. Exclusive soyabean LE had the highest content of PS (422·36 (sd 130·46) μg/ml). In part II, patient study: nineteen patients were included. In the O/S group, PS levels were maintained (1·11 (sd 6·98) μg/ml) from day 0 to 7, while in the FO group, significant decreases were seen in total PS (-6·21 (sd 4·73) μg/ml) and their fractions, except for campesterol and stigmasterol. Plasma PS on day 7 were significantly associated with PS administered (R2 0·443). PS content in different LE brands had great variability. PS administered during PN resulted in accumulation and could be prevented with the exclusive administration of FO LE.

Identifiants

pubmed: 32077392
pii: S0007114520000574
doi: 10.1017/S0007114520000574
doi:

Substances chimiques

Fat Emulsions, Intravenous 0
Fish Oils 0
Parenteral Nutrition Solutions 0
Phytosterols 0
Plant Oils 0
campesterol 5L5O665639
Cholesterol 97C5T2UQ7J
Stigmasterol 99WUK5D0Y8

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1365-1372

Auteurs

Josep M Llop-Talaveron (JM)

Pharmacy Department, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

Elisabet Leiva-Badosa (E)

Pharmacy Department, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

Ana Novak (A)

Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.

Raúl Rigo-Bonnin (R)

Biochemistry Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Josep R Ticó-Grau (JR)

Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.

Josep M Suñé-Negre (JM)

Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.

Ana Suárez-Lledó (A)

Pharmacy Department, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Toni Lozano-Andreu (T)

Pharmacy Department, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Maria B Badía-Tahull (MB)

Pharmacy Department, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH